NASDAQ · Healthcare · Biotechnology
InMed Pharmaceuticals Inc.
INM
InMed Pharmaceuticals Inc. CEO Eric A. Adams Chem. · Market cap $2.8M.
$1.54
+0.03 · +1.99%
52w hi $3.3552w lo $0.57
Off 52w high 72.5%
64
NOTABLE
Current InsiderScore
Corp · 90d
8
8 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
0 strong · 2 notable
Analyst consensus
Strong Buy
—
Section 01
Recent Form 4 filings
8 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 08 | Vivo Opportunity, LLC | Buy | 29,518 | $1.52 | +$45K | 35 | |
| Jun 05 | Vivo Opportunity, LLC | Buy | 49,966 | $1.57 | +$78K | 54 | |
| Jun 02 | Vivo Opportunity, LLC | Buy | 20,753 | $1.52 | +$32K | 35 | |
| May 29 | Vivo Opportunity, LLC | Buy | 16,164 | $1.57 | +$25K | 35 | |
| May 21 | Vivo Opportunity, LLC | Buy | 30,882 | $1.69 | +$52K | 54 | |
| May 20 | Vivo Opportunity, LLC | Buy | 51,056 | $1.56 | +$80K | 57 | |
| May 19 | ADAR1 Capital Management, LLC | Buy | 68,551 | $1.60 | +$110K | 60 | |
| May 19 | ADAR1 Capital Management, LLC | Buy | 200,000 | $1.56 | +$312K | 64 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun